The US stock market just recorded its worst first 100 days of any presidential term since President Gerald Ford assumed office in 1974.

U.S. stocks were on pace to close out Donald Trump’s first 100 days back in the Oval Office on a sour note, with the president’s trade policies taking the blame for derailing a thriving market and stoking fears the world’s largest economy could slip toward recession.

History indicates that investors should expect an overall gain in stocks for the rest of Trump’s term. But market returns have been lower when stocks were down in a president’

Health and wellness company, which sold alternatives to weight-loss drugs like Wegovy, is now collaborating with Wegovy-maker Novo Nordisk.

Him & Hers Health and Novo Nordisk are collaborating to offer weight-loss treatment, including access to Wegovy along with other services to treat obesity.

Key Takeaways Hims & Hers Health shares surged Tuesday as the company announced a partnership with Danish drugmaker Novo Nordisk.Hims & Hers users will have access to Novo Nordisk's Wegovy starting this week,